13 Feb. 2019

Eli Pikarsky

Hepatocellular Carcinoma
Hosted by Maria Reig

  • Wednesday, 13th
  • 16h / IDIBAPS
  • BCN

Hepatocellular Carcinoma

The LiverSeminars Program is an educational activity in which experts in the Hepatology field will come to one of the two organizing institutions (IDIBAPS in Barcelona, IiSGM in Madrid) to spend a whole day sharing basic and translational science. Visits will always have the same agenda: during the morning, the Expert will be able to meet in private with scientists from research centres geographically close to the Institution that welcomes him (please book your time slot at the “meet the speaker” tab), in the afternoon we will have the seminar itself that will be live broadcasted to the Institute that does not host the speaker. Please note that activities are not restricted to the personnel from the organizing institutions. In this page you will find detailed information about the invited Speakers and scientific topics that will be covered during this academic year.
  • 9.00 -10.00 h Available slot-times to meet ELI PIKARSKY
  • 9.00 -10.00 h Available slot-times to meet ELI PIKARSKY
  • 11.00 -12.00 h Available slot-times to meet ELI PIKARSKY
  • 12.00 -13.00 h Available slot-times to meet ELI PIKARSKY

Eli Pikarsky, MD PhD

Eli Pikarsky earned his MD and PhD at the Hebrew University-Hadassah Medical School and was trained as a pathologist at the Hadassah-Hebrew University Medical Center. He is a professor of pathology and the chairman of the department of pathology at the Hadassah-Hebrew University medical Center and is a member of the Lautenberg Center for Immunology and Cancer Research at the Hebrew University Medical School. He divides his time between research, teaching and clinical activity. He is the chairman of the research committee of the Israel Cancer Association, a member of the board of the Israel Association for Cancer Research and the Board of European Association for Cancer Research.
His research interests lie at the intersection of cancer biology, inflammation and histopathological studies of mouse models of human disease. The primary focus of his group is understanding tissue aspects of cancer development in mouse models. His studies involve analysis of the interaction between inflammation and cancer cells paying attention to the roles of relevant signaling pathways in particular cell types. Along the years he has elucidated several mechanisms through which inflammation promotes cancer progression, in particular liver cancer. He is also dissecting regenerative and inflammatory processes in the liver.


Find below the video recording as soon as it is available.


The LiverSeminars Program is distributed along the 2017/18 academic year. Find herein the upcoming seminars.


The LiverSeminars Program is possible thanks to the support from these private and public entities.